specification: FinOps Framework specificationVersion: '1.0' schema: https://www.finops.org/framework/ alignedWith: framework: FinOps Foundation Framework frameworkUrl: https://www.finops.org/framework/ dataSpec: FOCUS dataSpecVersion: '1.3' dataSpecUrl: https://focus.finops.org/focus-specification/v1-3/ provider: Amgen providerId: amgen publisherName: Amgen Inc. serviceCategory: Biopharmaceutical created: '2026-05-04' # Provenance stamped 2026-08-11: this artifact was written by the API Evangelist # bulk sweep dated 2026-05-04, not harvested from the provider. See roadmap#35. method: generated modified: '2026-05-05' reconciled: false tags: - FinOps - FOCUS - Biotechnology - Biopharmaceutical description: >- FOCUS-aligned FinOps placeholder for Amgen. Amgen has no public API metered billing surface; commercial spend on Amgen relates to therapy procurement through GPOs, distributors, and payers, which sits outside API FinOps. notes: >- No public API billing surface. sources: - https://www.amgen.com billingModel: pricingCategory: Not Applicable billingFrequency: Not Applicable billingCurrency: USD chargeCategories: - Purchase focusColumns: ServiceName: Amgen ServiceCategory: Biopharmaceutical ProviderName: Amgen PublisherName: Amgen Inc. InvoiceIssuerName: Amgen Inc. BillingCurrency: USD meters: - name: api_requests description: Placeholder; not billed as a developer line item unit: request aggregation: sum dimensions: - consumer principles: - name: Visibility description: >- No Amgen-issued developer telemetry. Therapy spend visibility lives in payer / distributor systems. - name: Allocation description: >- Allocate Amgen-related costs through procurement and clinical operations, not API consumer tags. - name: Optimization description: >- Optimization levers (formulary, prior auth, biosimilar substitution) are outside developer scope. - name: Accountability description: >- Budget ownership sits with pharmacy, clinical, and procurement leaders. maintainers: - FN: API Evangelist email: info@apievangelist.com